Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
May 30, 2025, 3:30 PM EDT - 25 days ago
AGNG ARKG BBC BBH BBP BIB BIS
Feb 25, 2025, 11:06 AM EST - 4 months ago
IBB XLV AGNG ARKG BBC BBH BBP
Jan 11, 2023, 6:09 PM EST - 2 years ago
AGNG ARKG BBC BBH BBP BMED CNCR
Aug 27, 2022, 4:45 AM EDT - 3 years ago
ARKG BBH BIB FBT GNOM IBB IBBQ